CAM
ANGO icon

Cresset Asset Management’s AngioDynamics ANGO Stock Holding History

Cresset Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-163
Closed -$4K – 541
2019
Q1 		$4K Hold
163
– – ﹤0.01% 1402
2018
Q4 		$3K Buy
+163
New +$3.37K ﹤0.01% 1160

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TCM
Tributary Capital Management Omaha, Nebraska $1.22B AUM 44.12% 1-Year Est. Return

Cresset Asset Management's ANGO Position: Q2 2019 in Review

Cresset Asset Management sold out of AngioDynamics (ANGO) in Q2 2019, closing a stake of 163 shares — an estimated $4K sold.

Cresset Asset Management first reported a position in ANGO in Q4 2018 and held it in 2 quarters. The position peaked at $4K in Q1 2019. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2019.

  • Cresset Asset Management reported no remaining AngioDynamics position as of Q2 2019 after selling out during the quarter.
  • Cresset Asset Management sold 163 AngioDynamics shares in Q2 2019, an estimated $4K.
  • Cresset Asset Management first reported a position in AngioDynamics in Q4 2018 and held it in 2 quarters.
  • Cresset Asset Management's AngioDynamics position peaked at $4K in Q1 2019.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2019.

Based on Cresset Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.